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Objectives: From the introduction of HIV into the Republic of Korea in 1985
through 2012, 9,410 HIV-infected Koreans have been identified. Since 2000, there
has been a sharp increase in newly diagnosed HIV-infected Koreans. It is neces-
sary to estimate the changes in HIV infection to plan budgets and to modify HIV/
AIDS prevention policy. We constructed autoregressive integrated moving average
(ARIMA) models to forecast the number of HIV infections from 2013 to 2017.
Methods: HIV infection data from 1985 to 2012 were used to fit ARIMA models.
Akaike Information Criterion and Schwartz Bayesian Criterion statistics were used
to evaluate the constructed models. Estimation was via the maximum likelihood
method. To assess the validity of the proposed models, the mean absolute per-
centage error (MAPE) between the number of observed and fitted HIV infections
from 1985 to 2012 was calculated. Finally, the fitted ARIMA models were used to
forecast the number of HIV infections from 2013 to 2017.
Results: The fitted number of HIV infections was calculated by optimum ARIMA
(2,2,1) model from 1985e2012. The fitted number was similar to the observed
number of HIV infections, with a MAPE of 13.7%. The forecasted number of new
HIV infections in 2013 was 962 (95% confidence interval (CI): 889e1,036) and in
2017 was 1,111 (95% CI: 805e1,418). The forecasted cumulative number of HIV
infections in 2013 was 10,372 (95% CI: 10,308e10,437) and in 2017 was14,724 (95%
CI: 13,893e15,555) by ARIMA (1,2,3).
Conclusion: Based on the forecast of the number of newly diagnosed HIV in-
fections and the current cumulative number of HIV infections, the cumulative
number of HIV-infected Koreans in 2017 would reach about 15,000.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
) which permits unrestricted non-commercial use, distribution, and reproduction in any
operly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
Forecasting HIV infection using ARIMA model 3591. Introduction
Human immunodeficiency virus (HIV) infection can
show nonspecific symptoms in the early stage such as
anorexia, weight loss, fever, lymph node enlargement,
and fatigue, but has a long asymptomatic period after
an acute infection period. Therefore, the real preva-
lence of HIV infection has been estimated to be more
than the reported numbers. Since the first reported case
of AIDS, the United Nations Programme on HIV/AIDS
(UNAIDS) estimated the global people living with
HIV/AIDS (PLWHA) to be 35.3 million in 2012 [1].
The cumulative number of HIV-infected people iden-
tified in the Republic of Korea from 1985 to 2012 was
10,453 (9,410 Koreans, 1,043 foreigners), relatively
low compared to many other countries [2]. However,
since 2000, the number of the HIV infected people in
Korea has sharply increased; 800 to 1,000 persons are
newly identified each year in the recent 3 years [2], and
it is questionable whether this increasing trend will
continue.
The United States stated the research on estimation
in 1980, and many countries have estimated the HIV-
infected persons using the model suggested by
UNAIDS for identifying the trend of their own nation.
The method to estimate incidence, prevalence, the
number of infected persons, and the number of deaths
has been improved since its development in late 1980.
It includes the back calculation method, ratio method,
Delphi survey method, mathematical and computer/
simulation models, and Epimodel. No single optimal
estimation method exists; each method has its own
characteristics. Recent standard methods for estima-
tion and prediction are the workbook method, esti-
mation and projection package (EPP) method, and
time series method (autoregressive moving average
model).
As for the estimation of HIV-infected Koreans, the
back calculation method, Epi-info model, and EPP
model cannot be applied because of limitations
including: the lack of exact statistics on AIDS cases
and no specific information available for commercial
sex workers (CWSs), intravenous drug users (IDUs),
and the sexually transmitted infection risk group (STI
RG). However, the autoregressive integrated moving
average (ARIMA) time series method utilizes auto-
correlation and can produce an estimation model with
information on HIV cases identified yearly or monthly.
ARIMA is used for the estimation of influenza mor-
tality [3], malaria incidence [4], and other infectious
diseases [5e7].
This study aimed to construct estimation models
using the annual number of newly identified HIV-
infected Koreans in Korea from 1985 to 2012, and to
forecast the number of HIV cases and the trend in
epidemiological characteristics.2. Materials and Methods
2.1. Materials
This study has utilized 9410 identified HIV-infected
persons’ basic epidemiological data, including diag-
nosed year, sex, age, screening site, and date of death
from 1985 to 2012 in Korea. The local public health
centers conduct an epidemiological investigation on the
route of infection once the HIV-infected persons are
identified and report the results to the Korea Centers for
Disease Control and Prevention (KCDC). The epide-
miological data are managed by the KCDC HIV data-
base system. The data for this study were collected from
the KCDC HIV database system.
2.2. Methods
ARIMA models are the most commonly used time se-
ries prediction models. We constructed ARIMA models
with data from HIV cases in Korea from 1985e2012, to
forecast the annual number of newly diagnosed HIV-
infected Koreans and to forecast the cumulative number of
HIV cases in the next 5 years (2013e2017). To determine
the degree ofARIMA,we have utilized the autocorrelation
function (ACF) and partial autocorrelation function
(PACF) graphs and constructed an optimal model on the
basis of Akaike’s information criterion (AIC) statistic and
Schwartz’s Bayesian criterion (SBC) statistic. Conditional
least squares method (CLS) was used for parameter
estimation.
This study constructed models by sex, age, and
screening site, similar to that of the study by Debanne et al
[8]; as a result, the sums of the forecasting numbers by
variables are not equal to the forecasting number of newly
diagnosed HIV cases. Forecasting numbers were calcu-
lated based on a percentage of the forecasting value of
each category by each variable. To check the accuracy of
each model, mean absolute percentage errors (MAPE)
between the number of observed and fitted HIV infections
from 1985 to 2012were calculated. Finally, the number of
HIV-infectedKoreans in each year from 2013e2017were
forecasted. SAS version 9.3 (SAS Institute, Cary, NC,
USA) was used for data analysis.3. Results
3.1. Status of HIV-infected persons in Korea
until 2012
Figure 1 depicts the number of people with HIV in
Korea from 1985 to 2012. The cumulative number of
HIV-infected Koreans through 2012 is 9,410 (8,668
men, 742 women), and the number of PLWHA is 7,788
(7,165 men, 624 women). The number of HIV case
sharply increases from 2000 to 2008. However, the past
5 years have shown a lower increase of newly diagnosed
cases.
Figure 1. The trend in the number of HIV-infected Koreans, 1985e2012. The bars are the number of newly diagnosed HIV-
infected Koreans, the dotted red line is the cumulative number of HIV-infected Koreans, and the yellow triangle line is the number
of AIDS deaths per year.
360 H.-K. Yu, et al3.2. Construction of models to estimate the
number of HIV-infected persons, and
forecast of 2013e2017
Figure 2 represents observed yearly data
(1985e2012), predicted values, and 95% confidence
intervals (CI) for the predicted values. Most of observedFigure 2. Comparison of the reported and forecasted numbers of
actual number, dot line: forecasted number, band: 95% confidence
HIV-infected Koreans, (b) the number of newly diagnosed HIV-infe
male Koreans, and (d) the number of newly diagnosed HIV infectdata are contained within the 95% CI of the predicted
value, indicating that the fitted models are reasonable.
The forecasts of each ARIMAmodel for the number of
HIV-infected Koreans in 2013e2017 are shown in
Table 1. Each model shows the number of HIV-infected
Koreans increases each year, so the data were stabilized byHIV cases in Korea from 1985 through 2012. Diamond line:
interval of forecasted number. (a) The cumulative number of
cted Koreans, (c) the number of newly diagnosed HIV infected
ed female Koreans.
Table 1. The forecasted number of HIV-infected Koreans in Korea in 2013e2017
Characteristics Model
Forecast
2013 2014 2015 2016 2017
Cumulative HIV cases ARIMA (1,2,3) 10,372 (10,308e10,437) 11,425 (11,275e11,574) 12,470 (12,170e12,770) 13,595 (13,058e14,131) 14,724 (13,893e15,555)
People living with HIV ARIMA (1,2,2) 8,615 (8,533e8,698) 9,508 (9,325e9,691) 10,438 (10,075e10,802) 11,391 (10,768e12,013) 12,355 (11,404e13,306)
Newly-diagnosed HIV cases ARIMA (2,2,1) 962 (889e 1,036) 992 (882e1,102) 1,026 (856e1,196) 1,108 (867e1,349) 1,111 (805e1,418)
Sex
Man ARIMA (1,2,2) 902 (838e966) 934 (845e1,022) 969 (811e1,127) 1050 (801e1,299) 1055 (723e1,388)
Woman ARIMA (2,1,2) 60 (48e72) 58 (47e70) 57 (43e70) 58 (43e73) 56 (39e72)
Age
<20 ARIMA (1,2,1) 44 (37e51) 42 (34e51) 51 (39e64) 54 (39e69) 56 (38e74)
20e29 ARIMA (1,1,1) 302 (260e344) 318 (254e382) 369 (276e463) 401 (282e521) 414 (273e554)
30e39 ARIMA (1,2,0) 205 (169e242) 200 (143e258) 212 (111e312) 214 (73e355) 204 (23e385)
40e49 ARIMA (2,2,0) 185 (151e218) 203 (161e245) 155 (96e213) 188 (96e279) 190 (85e296)
50e59 ARIMA (2,2,0) 148 (126e171) 153 (123e183) 163 (117e208) 173 (107e239) 172 (92e251)
60 ARIMA (2,2,0) 78 (58e97) 76 (44e108) 76 (31e122) 78 (13e143) 75 (0e157)
Screening site
Public institution ARIMA (2,1,2) 145 (99e192) 134 (75e193) 135 (65e205) 153 (65e241) 164 (60e269)
Hospital ARIMA (1,1,2) 714 (628e799) 743 (626e860) 780 (600e960) 829 (568e1089) 830 (499e1161)
Blood bank ARIMA (1,1,1) 103 (82e125) 115 (85e144) 111 (72e149) 126 (81e173) 117 (65e169)
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362 H.-K. Yu, et aldifference and fitted. The MAPE for the cumulative
number of HIV-infected Koreans is 5.5%, for the cumu-
lative number of PLWHA is 6.3%, and for the number of
newly-diagnosed HIV-infected Koreans is 13.7%. By
2017, these models estimate that Korea will have a cu-
mulative number of HIV-infectedKoreans of 14,724 (95%
CI; 13,893e15,555), and a cumulative PLWHA of 12,355
(95% CI: 11,404e13,306). A total of 1,111 (95% CI:
805e1,418) Koreans are estimated to be newly diagnosed
with HIV in 2017. Analysis by epidemiological charac-
teristic shows that the difference between men and women
will be greater in 2017: 1,288 men (95% CI: 882e1,693)
vs. 68 women (95% CI: 48e87). The age group in which
the largest number of HIV-infected Koreans is expected to
be diagnosed is 20e29, with an average of 387 persons in
their twenties (95% CI; 255e518) being newly diagnosed
per year. HIV-infected Koreans are expected to be mostly
diagnosed in hospitals, followed by public health centers
and then blood banks.4. Discussion
Models reveals that by 2017 the cumulative number of
HIV-infected Koreans will be 14,724, with 12,355 cu-
mulative PLWHA, and 1,111 newly diagnosed persons in
the year 2017. It took 29 years since the first diagnosis of
HIV infection in 1985 to identify a cumulative number of
10,000 HIV-infected people in Korea. This study sug-
gests that the cumulative trend will increase dramatically,
to 14,724 in 2017 and over 15,000 in 2018, for an increase
of 5,000 in 6 years. The number of newly diagnosed HIV-
infected Koreans is also expected to increase, with more
than 1,000 per year after 2014.
The current gender difference (11:1 men to women)
is expected to widen even further; the gender ratio of
newly diagnosed HIV-infected Koreans will be 19:1 in
2017. By 2012, the age group with the highest cumu-
lative number of HIV-infected Koreans was 30e39
(29%), but there is also a recent increase of HIV-
infected Koreans in their twenties. Based on the results
of this study, we can expect a sharp increase of HIV-
infected Koreans in their twenties for the upcoming 5
years. Increases in the number of teens and those in their
fifties are also forecasted. This result suggests that a
main target group for prevention should be those aged
20e29 in Korea. In previous studies on STIs prevalence
(HIV and HSV-2), the prevalence were low in Koreans
in their twenties [9e11], but it is necessary to monitor
this age group carefully for any changes.
This study has at least one limitation: the fitted
models using the number of HIV-infected Koreans
during 1985e2012 assume that past HIV infection pat-
terns are identical to future patterns, so if the patterns aredifferent, the estimated error will be greater and the
forecasts will be less accurate.
Korea took an active HIV/AIDS prevention policy
with its first diagnosis of HIV infection in 1985, and
then expanded HIV testing into specific target groups.
Since 1998, Korea has reduced the scope and shifted the
policy to voluntary HIV testing with more emphasis on
prevention and support of treatment cost of HIV infected
persons. This study can be used to estimate the scale of
the Korean Government’s budget for HIV/AIDS pre-
vention and treatment, as well as inform changes to the
HIV/AIDS prevention policy.
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